April 14, 2024



Andreas Grauer will oversee all clinical activities at Omeros, a Seattle-based biopharmaceutical company developing treatments aimed at cancer, addiction and compulsive disorders.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *